📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients (2024)

First Author: Guo Y

Attributed to: MICA: Senolytic therapies for chronic obstructive pulmonary disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/13993003.congress-2024.pa897

Publication URI: http://dx.doi.org/10.1183/13993003.congress-2024.pa897

Type: Conference/Paper/Proceeding/Abstract